company background image
CBDL logo

CBD Life Sciences OTCPK:CBDL Stock Report

Last Price

US$0.0005

Market Cap

US$1.1m

7D

25.0%

1Y

66.7%

Updated

24 Dec, 2024

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

CBD Life Sciences Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for CBD Life Sciences
Historical stock prices
Current Share PriceUS$0.0005
52 Week HighUS$0.03
52 Week LowUS$0.0003
Beta53.63
1 Month Change-9.09%
3 Month Change-28.57%
1 Year Change66.67%
3 Year Change-99.33%
5 Year Change-99.88%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

CBDLUS PharmaceuticalsUS Market
7D25.0%1.6%-2.2%
1Y66.7%9.7%23.9%

Return vs Industry: CBDL exceeded the US Pharmaceuticals industry which returned 9.7% over the past year.

Return vs Market: CBDL exceeded the US Market which returned 23.9% over the past year.

Price Volatility

Is CBDL's price volatile compared to industry and market?
CBDL volatility
CBDL Average Weekly Movement54.4%
Pharmaceuticals Industry Average Movement10.4%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: CBDL's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CBDL's weekly volatility has decreased from 4969% to 54% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a4Lisa Nelsonlbcbioscienceinc.com

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. The company is based in Scottsdale, Arizona.

CBD Life Sciences Inc. Fundamentals Summary

How do CBD Life Sciences's earnings and revenue compare to its market cap?
CBDL fundamental statistics
Market capUS$1.11m
Earnings (TTM)-US$107.44k
Revenue (TTM)US$178.45k

7.8x

P/S Ratio

-12.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBDL income statement (TTM)
RevenueUS$178.45k
Cost of RevenueUS$98.04k
Gross ProfitUS$80.41k
Other ExpensesUS$187.84k
Earnings-US$107.44k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.000039
Gross Margin45.06%
Net Profit Margin-60.21%
Debt/Equity Ratio0%

How did CBDL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 01:28
End of Day Share Price 2024/12/24 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CBD Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution